Business Briefs 07-08-2014
StanChart net dips Lupin pact Bharti Airtel Realty trusts
- Published 7.08.14
Mumbai, Aug. 6: British lender Standard Chartered Bank today reported a 10 per cent dip in operating profit from the country at $395 million for the first six months of 2014. The bank, which is listed on the Indian bourses through Indian depository receipts, had a profit of $439 million last year.
New Delhi, Aug 6: Drug major Lupin has inked a marketing pact with South Korea’s LG Life Sciences to launch anti-diabetes drug in India. Mumbai-based Lupin will launch LG Life Sciences’ Insulin Glargine under the brand name BasugineTM.
New Delhi, Aug 6: Bharti Airtel plans to raise at least Rs 2,125 crore by selling up to 8.5 crore shares in its tower business unit Bharti Infratel via stock exchanges at a floor price of Rs 250 per share tomorrow.
New Delhi, Aug. 6: The government has decided to provide significant tax benefits to listed business trusts such as real estate and infrastructure investment trusts.